{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:18:50Z","timestamp":1769811530640,"version":"3.49.0"},"reference-count":100,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"vor","delay-in-days":1926,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Drug Reviews"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Raloxifene hydrochloride binds to the estrogen receptor and shows tissue\u2010selective effects; thus, it belongs to a class of drugs recently described as<jats:italic>selective estrogen receptor modulators<\/jats:italic>(SERMs). Tissue selectivity of raloxifene may be achieved through several mechanisms: the ligand structure, interaction of the ligand with different receptor subtypes in various tissues, and intracellular events after ligand binding. Raloxifene has estrogen\u2010agonist effects on bone and lipids and estrogen antagonist effects on the breast and uterus. In addition to its well established effects on osteoporosis, recent preclinical and clinical findings suggest that raloxifene also possesses beneficial effects on the cardiovascular system. These findings indicated that raloxifene may have cardioprotective properties without an increased risk of cancer or other side effects. Raloxifene has been shown to reduce total and low\u2010density lipoprotein cholesterol concentrations in plasma, an effect similar to that produced by estrogens. Unlike estrogens, however, raloxifene does not increase high\u2010density lipoprotein cholesterol and triglyceride levels in plasma. Endothelium is thought to play an important role in the genesis of atherosclerosis. Several lines of evidence suggest that an intervention with endothelial function might influence the progression of coronary disease and the incidence of cardiovascular events. Raloxifene increases the nitric oxide\/endothelin\u20101 ratio, and improves endothelium\u2010dependent vasomotion in post\u2010menopausal women to the same extent as estrogens. Furthermore, in two randomized trials on post\u2010menopausal women raloxifene reduced homocysteine levels, another independent risk factor for the development of cardiovascular disease. Although estrogens remain the drugs of choice in the hormonal therapy of most postmenopausal women, raloxifene may represent an alternative in women who are at risk of coronary artery disease.<\/jats:p>","DOI":"10.1111\/j.1527-3466.2001.tb00183.x","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T10:48:26Z","timestamp":1281955706000},"page":"57-74","source":"Crossref","is-referenced-by-count":40,"title":["Cardiovascular Effects of Raloxifene Hydrochloride"],"prefix":"10.1111","volume":"19","author":[{"given":"Antonino","family":"Saitta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunziate","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Frisina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cucinotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"D'Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenica","family":"Altavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letteria","family":"Minutoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Arcoraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cancellieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00314-2"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.2.123"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1210\/endo.138.11.5652","article-title":"Differential expression of estrogen receptors a and b mRNA during differentiation of human osteoblast SV\u2010HFO cells","volume":"138","author":"Arts J","year":"1997","journal-title":"Endocrinology"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199601000-00021"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.1.6"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460140089033"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404143301508"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90935-9"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116985"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.1964"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70091-7"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114477"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/39645"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000159147"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000226637"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.14.5.753"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00189-7"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.17.11384"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.3.721"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322401"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00689672"},{"key":"e_1_2_1_23_2","article-title":"Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in post\u2010menopausal women. Two\u2010year findings from the multiple outcomes of raloxifene evaluation (MORE) trial [Abstract]","volume":"3","author":"Cummings SR","year":"1998","journal-title":"Proceedings of the American Society of Clinical Oncology Meeting"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712043372301"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804303381814"},{"key":"e_1_2_1_26_2","first-page":"2993","article-title":"Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women; a 2\u2010year, placebo\u2010controlled study","volume":"12","author":"Roo GW","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00008-3"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.7.2371"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000139284"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650110615"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0022-3565(25)38705-7","article-title":"Vasodilator\u2010derived nitric oxide inhibits fetal calf serum and angiotensin\u2010II\u2010induced growth of renal arteriolar smooth muscle cells","volume":"269","author":"Dubey RK.","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.10.5.477"},{"key":"e_1_2_1_33_2","volume-title":"Evista (raloxifene) tablets product monograph [Package insert]","year":"1997"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.10.5.8621060"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.10.1095"},{"issue":"1","key":"e_1_2_1_36_2","first-page":"S282","article-title":"In vivo and in vitro metabolism of raloxifene [Abstract]","volume":"8","author":"Frolik CA","year":"1993","journal-title":"J Bone Miner Res"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb31392.x"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(199611)17:3<151::AID-MC7>3.0.CO;2-I"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90422-B"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.6.2545"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.2.786"},{"key":"e_1_2_1_42_2","first-page":"4020","article-title":"Antitumor actions of keoxifene and tamoxifen in the N\u2010nitrosomethylurea\u2010induced rat mammary carcinoma model","volume":"47","author":"Gottardis MM","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_1_43_2","first-page":"3189","article-title":"Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen\u2010stimulated human endometrial carcinoma (EnCa101) in atymic mice","volume":"50","author":"Gottardis MM","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9606352"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.14105"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608153350701"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8197458"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.3.1357"},{"key":"e_1_2_1_49_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"380","author":"Hulley S","year":"1998","journal-title":"JAMA"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240590808"},{"key":"e_1_2_1_51_2","article-title":"Incident primary breast cancers are reduced by raloxifene: Integrated data from multicenter, double\u2010blind, randomized trials in ~ 12,000 postmenopausal women [Abstract]","volume":"466","author":"Jordan VC","year":"1998","journal-title":"Proceedings of the American Society of Clinical Oncology Meeting"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.10.2.119"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(87)90572-8"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703063361002"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.12.5925"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.3.4979"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.9.2426"},{"key":"e_1_2_1_58_2","first-page":"4177","article-title":"Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award Lecture","volume":"50","author":"Lerner LJ","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502233320807"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-12-199412150-00005"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498258409151482"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(05)80001-5"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)64842-8"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.9.6.659"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001573-199607000-00002"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(94)90215-1"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(98)00381-1"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-199906020-00010"},{"key":"e_1_2_1_69_2","article-title":"Randomized, double\u2010blind, placebo controlled study on the effects of raloxifene and hormone replacement therapy on plasma nitric oxide concentrations, endothelin\u20101 levels and endothelium\u2010dependent vasodilatation in postmenopausal women","author":"Morabito N","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.3.755"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00782-X"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.6.961"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-2-962"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5331.1508"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90371-5"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.1.52"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.7.2417"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.4.848"},{"key":"e_1_2_1_79_2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(25)20968-5","article-title":"Advantages of raloxifene over alendornate or estrogen on nonreproductive tissues in the long\u2010term dosing of ovariectomized rats","volume":"279","author":"Sato M","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.11.3071"},{"key":"e_1_2_1_81_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6","article-title":"Comparative distribution of estrogen receptor \u03b1 and beta; mRNA in the rat central nervous system","volume":"388","author":"Shughrue PJ","year":"1997","journal-title":"J Comp Neurol"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(85)90131-5"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(96)00135-5"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.13.1234"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-7435(91)90006-P"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199109123251102"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.4.1095"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520270033028"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.135.5.7956922"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007053230106"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90417-N"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(84)90197-3"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.18.1445"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.1.214"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.9.4.443"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(88)90017-9"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.5.1680"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90184-8"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5279.1222"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.11.3384"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.16.1100"}],"container-title":["Cardiovascular Drug Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-3466.2001.tb00183.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-3466.2001.tb00183.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:50:31Z","timestamp":1740412231000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-3466.2001.tb00183.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1111\/j.1527-3466.2001.tb00183.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-3466.2001.tb00183.x","archive":["Portico"],"relation":{},"ISSN":["0897-5957","1527-3466"],"issn-type":[{"value":"0897-5957","type":"print"},{"value":"1527-3466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}